Previous post Next post

Drug makers paid Swiss doctors 12.5 million francs in 2017

© Pojoslaw | Dreamstime.com

Since 2016, drug makers have voluntarily published the amounts they pay to Swiss doctors, who prescribe drugs to patients. In 2017 the sum was CHF 12.5 million, according to the association Science Industries.

In 2016, the same figure was CHF 14 million.

While drug makers publish the amounts paid, the information published does not always reveal the names of doctors receiving the money. Consumers of health services are therefore not always able to see how much money their doctor might have received and whether it might have influenced their choice of drugs.

In 2017, Bayer dished out CHF 865,000, the most anonymous money. 62% of the total CHF 1.4 million it paid to Swiss doctors made its way into the pockets of unnamed doctors. In 2018, Bayer announced that it wanted to collaborate only with doctors willing to have their names revealed, according to RTS.

The Swiss Medical Association recognizes the risk of conflicts of interest and would like to see its members refrain from remaining anonymous when receiving money from drug makers.

Switzerland’s Federal Office of Public Health (FOPH) has said it wants to limit payments to doctors to CHF 300 from 2020. It thinks payments of this size won’t influence prescription drug choice.

In addition to the the effect this money could have on patients is the effect it could have on the collective cost of health care – doctors might be induced to prescribe similar but more expensive drugs.

To check how much money your doctor might have received you’ll need to go to every drug company’s website and search their name. For example to check for payments from Bayer click here – this shows whether your doctor received any of the 38% paid to those revealing their names.

Perhaps instead patients should develop a healthy habit of quietly asking their doctor if they have received any money from drug companies as they write out prescriptions. Boo!

Full story here
About Investec
Investec
Investec is a distinctive Specialist Bank and Asset Manager. We provide a diverse range of financial products and services to a niche client base in three principal markets, the United Kingdom, South Africa and Australia, as well as certain other geographies. Investec’s strategic goals are motivated by the desire to develop an efficient and integrated business on an international scale through the active pursuit of clearly established core competencies in the group’s principal business areas.
Previous post See more for 3) Swiss Markets and News Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2019/02/investec-drug-makers-paid-swiss-doctors-5-million-francs-2017/

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.